Dr. Mohammed Murtaza, MD

Dr. Murtaza practices at Jefferson Torresdale Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Murtaza's NPI, 1245214089, was assigned on December 5, 2005. Dr. Murtaza holds Pennsylvania license MD433927.

Dr. Murtaza's primary practice is Jefferson Torresdale Hospital, at 10800 Knights Road, Philadelphia, PA 19114 in Philadelphia County. The practice phone is (215) 612-4000.

Dr. Murtaza's primary practice is Jefferson Torresdale Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Murtaza is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Richboro Medical. Dmand AI also links Dr. Murtaza to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murtaza practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Murtaza's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Murtaza's licenses on file in 2 states: Pennsylvania and Missouri.

CMS data shows 3,710 Medicare services from Dr. Murtaza across 26 procedure codes in 2024, for 1,389 Medicare patients. Medicare paid $180,396 for them.

CMS counts 1,389 Medicare patients who saw Dr. Murtaza in 2024. The largest group is 65 to 74, with 536 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murtaza's median patient age at 74, with 47% women.

In 2024, Dr. Murtaza wrote 1,876 Medicare Part D claims for 316 patients. 88% of them were for generic drugs. CMS names the drug for 1,722 of them, across 33 drugs with 11 or more claims each, at $212,228 in total drug cost. In 2023, CMS named 2,092 claims across 32 drugs.

Dr. Murtaza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Murtaza as offering telehealth. CMS counts 67 procedures of coronary angioplasty and stenting by Dr. Murtaza, more than 91% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Murtaza, published from 2022 to 2024. Dr. Murtaza has published most often in Cureus. Dr. Murtaza's most frequent co-authors are Rene J. Alvarez, MD, Sona Franklin, MD and Eyad I. Kanawati, MD.

CMS Open Payments shows 157 general payments to Dr. Murtaza from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Edwards Lifesciences Corporation paid the most, $1,321.